Self-administered clinical hypnosis reduced hot flash frequency and severity by more than 50%, according to the results of a recent study published in Obstetrics and Gynecology.

For adult patients with hereditary hemorrhagic telangiectasia (HHT), a new, allosteric, selective activin receptor-like ...

COPD experimental therapy 9MW1911 reduced moderate to severe exacerbations in a Phase 2a trial, showing a favorable safety ...

Trevi Therapeutics stock (TRVI) earns a Buy rating as Haduvio advances toward phase 3 for chronic cough in IPF. Read the full ...

The meeting focused on Nexalin’s proposed clinical development plan and overall regulatory strategy for the Gen-2 SYNC ...

Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2 ...

MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive topline results from the Phase 2 clinical trial SUISSE-MPC2 (NCT05534269)evaluating its novel proprietary muscle ...

This peer-reviewed publication marks an important milestone following initial release of study information in August 2024 (see "Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT"). The ...

Western Kansas Therapy Associates (WKTA) is a behavioral health therapy office with two locations, in both downtown Hays and Phillipsburg. WKTA has a team of 17 licensed mental health therapists who ...

The global T-Cell lymphoma therapeutics market size was valued at US$ 2.3 Bn in 2024 and is projected to reach US$ 5.7 Bn by ...

Tumor treating fields are emerging as a promising option for treating a range of cancer types. Here’s a look at the evidence ...